A-1.6.2. Public Testimony

Complete and submit the Public Testimony Registration (HHS Form 1320). HHSC publishes a new form for each meeting. The form is available:

  • Online, beginning 10 days before the meeting
    • Original form submissions are required. We do not accept photographs or reproductions. Submit by email to HHSC.
  • At the meeting site

You may download and complete the form before the meeting. The form is only accepted the day of the meeting at the meeting location. Speakers should deliver their form during one of the following registration times:

  • Between 8 and 9 a. m. for preferred drug list agenda items
    • Scheduled for comment before the executive work session
  • Between 11:30 a. m. and 12:30 p. m. for prospective and retrospective drug utilization agenda items
    • Scheduled for comment after the executive session

HHSC staff are available on the day of the meeting to receive the form and ensure all information is provided.

Information about publicly testifying includes:

  • Testimony is limited to three minutes at the discretion of the Chair
  • Presenters should begin their presentation by stating their name and the organization represented and ensure your information is new and relevant to the agenda item
  • HHSC does not allow audiovisual equipment and marketing materials
  • The Chair may disallow presentations on non-actionable issues or issues not on the agenda or not within the Drug Utilization Review Board's responsibility.

Refer to the Forms section for a link to the registration form.